Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website now includes a security verification step for users, indicating a heightened focus on connection security, while extensive privacy-related content has been removed.
    Difference
    100%
    Check dated 2025-01-12T07:12:21.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Eli Lilly has made significant updates, including new privacy preferences for user data collection, multiple product approvals such as Zepbound® for sleep apnea and Kisunla™ for Alzheimer's in China, and a $15 billion share repurchase program.
    Difference
    100%
    Check dated 2024-12-28T23:35:34.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new addition (8f59ab0acb042f36) has been made, while an existing item (8f1e17e569502f3c) has been removed.
    Difference
    7%
    Check dated 2024-12-21T17:42:25.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new addition with ID 8f1e17e569502f3c has been made, while the item with ID 8ee3a6c5accf69da has been removed.
    Difference
    7%
    Check dated 2024-12-14T12:10:58.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website now includes a security verification step for users, indicating a heightened focus on connection security, while extensive privacy-related content has been removed.
    Difference
    100%
    Check dated 2024-12-07T09:57:32.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Eli Lilly has announced significant updates, including the election of Jon Moeller to its board of directors and promising results from clinical studies on muvalaplin and tirzepatide, which show potential benefits for cardiovascular health and heart failure management.
    Difference
    100%
    Check dated 2024-11-23T03:41:23.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.